Profile - To The Moon

JerriMaya

Posts · 2Posts · 2
Following · 0Following · 0
Followers · 0Followers · 0

- JerriMayaJerriMaya
  ·2021-03-15
  Great
  Merck and Gilead announce partnership for long-acting HIV treatments
  Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize lon
  Merck and Gilead announce partnership for long-acting HIV treatments
  156 Comment
  Like
  Share
  Report
- JerriMayaJerriMaya
  ·2021-02-10
  ?
  Ark's Cathie Wood explains how bitcoin could increase by $400,000
  Even before Tesla (TSLA) surprised the crypto markets with news of its $1.5 billion bitcoin (BTC-USD
  Ark's Cathie Wood explains how bitcoin could increase by $400,000
  181 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3571882228446581","uuid":"3571882228446581","gmtCreate":1608788205123,"gmtModify":1615860643158,"name":"JerriMaya","pinyin":"jerrimaya","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9f7eb555b2347804112b09a5f0e053b3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":9,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":322482974,"gmtCreate":1615820712498,"gmtModify":1704787120667,"author":{"id":"3571882228446581","authorId":"3571882228446581","name":"JerriMaya","avatar":"https://static.tigerbbs.com/9f7eb555b2347804112b09a5f0e053b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571882228446581","authorIdStr":"3571882228446581"},"themes":[],"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322482974","repostId":"1163783799","repostType":4,"repost":{"id":"1163783799","kind":"news","pubTimestamp":1615820076,"share":"https://ttm.financial/m/news/1163783799?lang=&edition=fundamental","pubTime":"2021-03-15 22:54","market":"us","language":"en","title":"Merck and Gilead announce partnership for long-acting HIV treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=1163783799","media":"seekingalpha","summary":"Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize lon","content":"<p>Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to&nbsp;co-develop and co-commercialize&nbsp;long-acting treatments targeting people living with HIV.</p><p>The combination will bring together two experimental therapies of companies: Gilead’s capsid inhibitor, lenacapavir, and Merck’s nucleoside reverse transcriptase translocation inhibitor, islatravir.</p><p>The initial focus of the collaboration will be an oral formulation, and its studies are set to begin in H2 2021.</p><p>Gilead and Merck will share global development and commercialization costs on a 60%/40% basis, respectively with Gilead leading the commercialization in the U.S. while Merck focuses on the EU and the rest of the world.</p><p>The companies will equally share the global product revenues until a certain threshold is met, and after net product sales for the oral combination reaches $2B a year, Gilead and Merck will apportion any revenues above the threshold on a ratio of 65%/ 35% respectively.</p><p>In January, ViiV Healthcare, a joint venture between GlaxoSmithKline(NYSE:GSK), Pfizer(NYSE:PFE)and Shionogi(OTCPK:SGIOY)received FDA approval for Cabenuva, cited as the first and only once-monthly, long-acting&nbsp;regimen for the treatment of HIV.</p><p><img src=\"https://static.tigerbbs.com/d47453449984c6102db13dec7df70ce3\" tg-width=\"1083\" tg-height=\"495\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/035b5e3b38df0268f87dd33a8bde94ca\" tg-width=\"1083\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck and Gilead announce partnership for long-acting HIV treatments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck and Gilead announce partnership for long-acting HIV treatments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 22:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two ...</p>\n\n<a href=\"https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","GILD":"吉利德科学"},"source_url":"https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1163783799","content_text":"Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two experimental therapies of companies: Gilead’s capsid inhibitor, lenacapavir, and Merck’s nucleoside reverse transcriptase translocation inhibitor, islatravir.The initial focus of the collaboration will be an oral formulation, and its studies are set to begin in H2 2021.Gilead and Merck will share global development and commercialization costs on a 60%/40% basis, respectively with Gilead leading the commercialization in the U.S. while Merck focuses on the EU and the rest of the world.The companies will equally share the global product revenues until a certain threshold is met, and after net product sales for the oral combination reaches $2B a year, Gilead and Merck will apportion any revenues above the threshold on a ratio of 65%/ 35% respectively.In January, ViiV Healthcare, a joint venture between GlaxoSmithKline(NYSE:GSK), Pfizer(NYSE:PFE)and Shionogi(OTCPK:SGIOY)received FDA approval for Cabenuva, cited as the first and only once-monthly, long-acting regimen for the treatment of HIV.","news_type":1},"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":381927075,"gmtCreate":1612923446297,"gmtModify":1704876065168,"author":{"id":"3571882228446581","authorId":"3571882228446581","name":"JerriMaya","avatar":"https://static.tigerbbs.com/9f7eb555b2347804112b09a5f0e053b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571882228446581","authorIdStr":"3571882228446581"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/381927075","repostId":"2110957120","repostType":4,"repost":{"id":"2110957120","kind":"news","pubTimestamp":1612915253,"share":"https://ttm.financial/m/news/2110957120?lang=&edition=fundamental","pubTime":"2021-02-10 08:00","market":"us","language":"en","title":"Ark's Cathie Wood explains how bitcoin could increase by $400,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2110957120","media":"Yahoo Finance","summary":"Even before Tesla (TSLA) surprised the crypto markets with news of its $1.5 billion bitcoin (BTC-USD","content":"<p>Even before Tesla (TSLA) surprised the crypto markets with news of its $1.5 billion bitcoin (BTC-USD) buy in January, disruption investor Cathie Wood and her team at Ark Invest had been modeling for more companies to use bitcoin as an alternative to cash on the balance sheet.</p><p>According to Ark’s Big Ideas for 2021, if all S&amp;P 500 companies were to allocate 1% of their cash to bitcoin, its price could increase by approximately $40,000. If those companies moved 10% of their cash to bitcoin, Ark sees the cryptocurrency climbing by $400,000.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/358694e862fa44441286cc96d69d6306\" tg-width=\"1368\" tg-height=\"992\" referrerpolicy=\"no-referrer\"><span>Ark Invest: Big Ideas 2021</span></p><p>Speaking to Yahoo Finance Presents shortly before Tesla became the first non-fintech Fortune 100 company to load up on bitcoin, Wood called Square (SQ) and MicroStrategy’s (MSTR) earlier bitcoin moves bullish for crypto and a roadmap for public companies to deploy bitcoin as a legitimate alternative to cash.</p><p>“What surprised me and us generally was to watch MicroStrategy — which has put... all the cash on its balance sheet into bitcoin — even did another equity offering so it could put more cash on its balance sheet. And I think that's a little crazy, because I think the regulators will have something to say about this,” Wood said. “But, then you saw Square put 1% of all of its assets in Bitcoin and I think you're going to see more of that.”</p><p>Tesla’s recent bitcoin investment amounts to about 8% of the company’s cash reserves.</p><p>Wood’s call for bitcoin to go higher this year has already been proven right. BTC hit an all time high of nearly $48,000 on Tuesday.</p><p>“Bitcoin is only [at] roughly a $600 billion market cap,” Wood says. “So even half the size of Apple or Amazon, right now. Doesn't that put it into perspective? And yet, it is a very big idea, I think. A much bigger idea than Apple or Amazon.”</p>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ark's Cathie Wood explains how bitcoin could increase by $400,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArk's Cathie Wood explains how bitcoin could increase by $400,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-10 08:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ark-cathie-wood-bitcoin-400000-000053537.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even before Tesla (TSLA) surprised the crypto markets with news of its $1.5 billion bitcoin (BTC-USD) buy in January, disruption investor Cathie Wood and her team at Ark Invest had been modeling for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ark-cathie-wood-bitcoin-400000-000053537.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKW":"ARK Next Generation Internation ETF","SQ":"Block","ARKQ":"ARK Autonomous Technology & Robotics ETF","TSLA":"特斯拉","ARKF":"ARK Fintech Innovation ETF","MSTR":"MicroStrategy","ARKG":"ARK Genomic Revolution ETF","ARKK":"ARK Innovation ETF"},"source_url":"https://finance.yahoo.com/news/ark-cathie-wood-bitcoin-400000-000053537.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110957120","content_text":"Even before Tesla (TSLA) surprised the crypto markets with news of its $1.5 billion bitcoin (BTC-USD) buy in January, disruption investor Cathie Wood and her team at Ark Invest had been modeling for more companies to use bitcoin as an alternative to cash on the balance sheet.According to Ark’s Big Ideas for 2021, if all S&P 500 companies were to allocate 1% of their cash to bitcoin, its price could increase by approximately $40,000. If those companies moved 10% of their cash to bitcoin, Ark sees the cryptocurrency climbing by $400,000.Ark Invest: Big Ideas 2021Speaking to Yahoo Finance Presents shortly before Tesla became the first non-fintech Fortune 100 company to load up on bitcoin, Wood called Square (SQ) and MicroStrategy’s (MSTR) earlier bitcoin moves bullish for crypto and a roadmap for public companies to deploy bitcoin as a legitimate alternative to cash.“What surprised me and us generally was to watch MicroStrategy — which has put... all the cash on its balance sheet into bitcoin — even did another equity offering so it could put more cash on its balance sheet. And I think that's a little crazy, because I think the regulators will have something to say about this,” Wood said. “But, then you saw Square put 1% of all of its assets in Bitcoin and I think you're going to see more of that.”Tesla’s recent bitcoin investment amounts to about 8% of the company’s cash reserves.Wood’s call for bitcoin to go higher this year has already been proven right. BTC hit an all time high of nearly $48,000 on Tuesday.“Bitcoin is only [at] roughly a $600 billion market cap,” Wood says. “So even half the size of Apple or Amazon, right now. Doesn't that put it into perspective? And yet, it is a very big idea, I think. A much bigger idea than Apple or Amazon.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}